Casper H.J. van Eijck mostly deals with Surgery, Pancreatitis, Internal medicine, Randomized controlled trial and Pancreatic cancer. His Surgery research includes themes of Relative risk and Clinical trial. His Pancreatitis research integrates issues from Interquartile range, Laparotomy, Acute pancreatitis, Prospective cohort study and Pancreatic disease.
His studies examine the connections between Internal medicine and genetics, as well as such issues in Gastroenterology, with regards to Pancreaticoduodenectomy and Odds ratio. His Randomized controlled trial research incorporates themes from Functional recovery, Gastric emptying and Treatment outcome. The Pancreatic cancer study combines topics in areas such as Gemcitabine, Chemoradiotherapy and Confidence interval.
Internal medicine, Surgery, Pancreatic cancer, Gastroenterology and Oncology are his primary areas of study. His work in the fields of Internal medicine, such as Neuroendocrine tumors, Prospective cohort study and Pancreas, intersects with other areas such as In patient. His research on Surgery frequently connects to adjacent areas such as Pancreatic fistula.
His Pancreatic cancer study combines topics from a wide range of disciplines, such as Cancer research, Radiology and Adenocarcinoma. The various areas that he examines in his Gastroenterology study include Incidence and Chemotherapy. His research integrates issues of Pancreatic disease and Acute pancreatitis in his study of Pancreatitis.
His primary scientific interests are in Internal medicine, Pancreatic cancer, Surgery, Oncology and Randomized controlled trial. His Internal medicine study frequently involves adjacent topics like Gastroenterology. His work in Gastroenterology covers topics such as Incidence which are related to areas like Neuroendocrine tumors.
His studies deal with areas such as Gemcitabine, Cancer research, Cancer registry and Immunotherapy as well as Pancreatic cancer. His Surgery study incorporates themes from Gastric emptying and Carcinoma. The concepts of his Randomized controlled trial study are interwoven with issues in Necrotizing pancreatitis, Pancreatitis, Clinical trial and MEDLINE.
Casper H.J. van Eijck mainly investigates Internal medicine, Pancreatic cancer, Randomized controlled trial, Surgery and FOLFIRINOX. His study brings together the fields of Gastroenterology and Internal medicine. His Pancreatic cancer research is multidisciplinary, incorporating perspectives in Cancer registry, Incidence, Oncology, Confidence interval and Gemcitabine.
His work in Randomized controlled trial tackles topics such as Pancreatitis which are related to areas like Quality of life and Clinical endpoint. His Surgery research incorporates elements of Clinical trial and Carcinoma. His FOLFIRINOX study integrates concerns from other disciplines, such as Chemoradiotherapy and Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
Dik J. Kwekkeboom;Wouter W. de Herder;Boen L. Kam;Casper H. van Eijck.
Journal of Clinical Oncology (2008)
A step-up approach or open necrosectomy for necrotizing pancreatitis
Hjalmar C. van Santvoort;Marc G. Besselink;Olaf J. Bakker;H. Sijbrand Hofker.
The New England Journal of Medicine (2010)
Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial
Marc G. H. Besselink;Hjalmar C. van Santvoort;Erik Buskens;Erik Buskens;Marja A. Boermeester.
The Lancet (2008)
Preoperative Biliary Drainage for Cancer of the Head of the Pancreas
Niels A van der Gaag;Erik A J Rauws;Casper H J van Eijck;Marco J Bruno.
The New England Journal of Medicine (2010)
Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors
Dik J. Kwekkeboom;Jaap J. Teunissen;Willem H. Bakker;Peter P. Kooij.
Journal of Clinical Oncology (2005)
Endoscopic transgastric vs surgical necrosectomy for infected necrotizing pancreatitis: a randomized trial.
Olaf J. Bakker;Hjalmar C. van Santvoort;Sandra van Brunschot;Ronald B. Geskus.
A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome.
Hjalmar C. van Santvoort;Olaf J. Bakker;Thomas L. Bollen;Marc G. Besselink.
Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors.
Khe T. C. Tran;Hans G. Smeenk;Casper H. J. van Eijck;Geert Kazemier.
Annals of Surgery (2004)
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker;Berend R Beumer;Eran Sadot;Lysiane Marthey.
Lancet Oncology (2016)
High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations.
Koen de Jong;C. Yung Nio;John J. Hermans;Marcel G. Dijkgraaf.
Clinical Gastroenterology and Hepatology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: